Using array-based genotyping profiles for COVID-19 cases and controls, researchers identified loci on chromosomes 3 and 9 that are linked to cases with respiratory failure.
The timing of the divergence of the Measles morbillivirus and Rinderpest morbillivirus lineages traces to about when human populations began to live in cities.
In April the firm received notice that it wasn't in compliance because its common stock didn't maintain a minimum bid price of $1.00 for 30 consecutive business days.
The company is providing DNA/RNA extraction kits, viral RNA isolation platforms, workstations, and kits for detecting nucleic acids from the coronavirus to the lab.
Todos said that it aims to develop an at-home 3C protease-based kit that uses a cell-phone camera and software for data analysis to test for the coronavirus.
The firm expects to validate its test as a triage tool to identify SARS-CoV-2 patients at risk of sepsis and pursue US FDA Emergency Use Authorization.
Roche will have non-exclusive access to SpeeDx's existing tests and technology to enable expansion of diagnostic products for antibiotic resistance in STIs.
Clinicians at Addenbrooke's Hospital in the UK are seeing reduced time to result and additional clinical benefits from using the DRW SAMBA II SARS-CoV-2 assay.
A comparative genomics and machine-learning analysis spanning almost 1,000 viral genomes pointed to two proteins that appear to be altered in SARS-CoV-2 and MERS-CoV.
The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.
